Game Plan Financial Advisors, LLC Bio Line Rx Ltd. Transaction History

Game Plan Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$1.46 - $2.18 $26,280 - $39,240	-18,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.98 - $3.06 $13,860 - $21,420	-7,000 Reduced 28.0%	18,000 $37,000
Q3 2021 Oct 26, 2021	SELL	$2.65 - $3.35 $10,600 - $13,400	-4,000 Reduced 13.79%	25,000 $69,000
Q2 2021 Jul 14, 2021	BUY	$2.63 - $4.88 $7,890 - $14,640	3,000 Added 11.54%	29,000 $81,000
Q1 2021 Apr 28, 2021	BUY	$2.38 - $4.0 $61,880 - $104,000	26,000 New	26,000 $74,000

3.3M

46.5K

6.3K

Ticker BLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,524,500
Market Cap $29.5M
Description
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.